Effect of Hygiene and Menstrual Hygiene Interventions on Learning and Psychosocial Wellbeing in Madagascar
KILONGA2
Disentangling the Effects of Infrastructure, Sensitization, and Sanitary Pad Distribution on Health, Learning, and Psychosocial Wellbeing Among Adolescent Girls in Rural Madagascar: A Cluster-Randomized Trial
2 other identifiers
interventional
3,080
1 country
1
Brief Summary
A previous study in schools in rural Madagascar found that a bundle of hygiene-focused interventions substantially improved girls' learning outcomes. This study disentangles the effects of physical infrastructure (latrines, handwashing basins) from other intervention components (peer sensitization and free sanitary pad distribution) in a cluster-randomized trial across 140 secondary schools in the Amoron'i Mania region. The trial originally measured learning and psychosocial wellbeing outcomes and was prospectively registered with the AEA RCT Registry (AEARCTR-0014423). The study team is now also collecting secondary health biomarker outcomes (e.g., salivary cortisol and blood-based C-reactive protein) and is registering those health biomarker endpoints with ClinicalTrials.gov.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 1, 2026
CompletedFirst Posted
Study publicly available on registry
July 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedJuly 14, 2026
June 1, 2026
1.8 years
July 1, 2026
July 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Learning - Academic Test Scores
Standardized math/literacy test scores and official school grades (140-school full evaluation sample and 80-school biomarker subsample)
Up to 19 months
Learning - School Grades
Official school grades (140-school full evaluation sample and and 80-school biomarker subsample)
Up to 19 months
Psychosocial Wellbeing - Heart Rate
Objective stress measure: heart rate, beats per minute (140-school full evaluation sample and 80-school biomarker subsample)
Up to 19 months
Psychosocial Wellbeing - Blood Pressure
Objective stress measure: systolic/diastolic blood pressure, mmHg (140-school full evaluation sample and 80-school biomarker subsample)
Up to 19 months
Psychosocial Wellbeing - Salivary Cortisol Reactivity
Salivary cortisol reactivity (80-school biomarker subsample). Cortisol reactivity, calculated as the area under the curve with respect to increase (AUCi), based on samples collected at clinic arrival (baseline), 5-8 minutes pre-venipuncture, and 20 minutes post-venipuncture. AUCi is calculated using the trapezoidal method: the area under the curve with respect to ground (AUCg) is first calculated by summing the areas of the trapezoids formed between each pair of consecutive cortisol values and their corresponding time interval, then subtracting the area under the baseline value across the total sampling duration. This is expressed as AUCg = Σ\[(Ci + Ci+1)/2 × Ti\], where Ci is the cortisol concentration at a given timepoint, Ci+1 is the concentration at the subsequent timepoint, and Ti is the time interval between them. AUCi = AUCg - (baseline cortisol × total sampling duration). Reported in µg/dL×min.
Up to 19 months
Menstrual stigma
Self-reported menstrual stigma (140-school full evaluation sample)
Up to 17 months
Secondary Outcomes (17)
Hygiene Knowledge
Up to 17 months
Hygiene Behavior
Up to 17 months
Menstrual Knowledge
Up to 17 months
Menstrual Behavior
Up to 17 months
Student/Teacher Motivation
Up to 17 months
- +12 more secondary outcomes
Study Arms (4)
Control
NO INTERVENTIONNo intervention
School infrastructure only
EXPERIMENTALConstruction of latrines and handwashing basins
Peer leadership/sensitization + sanitary pads
EXPERIMENTALYoung Girl Leaders program, teacher sensitization, WASH competition, free sanitary pad vouchers
Full package
EXPERIMENTALCombination of all interventions: Construction of latrines and handwashing basins and Peer leadership/sensitization + sanitary pads
Interventions
Young Girl Leaders program, teacher sensitization, WASH competition, free sanitary pad vouchers
Construction of latrines and handwashing basins
Eligibility Criteria
You may qualify if:
- Girl identified in the Kilonga 2 evaluation sample (randomly selected during the December 2024-January 2025 baseline from class registers across the 140 participating schools); participants were 11-20 years old at baseline enrollment and are approximately 12-21 years old at the time of endline/health-outcomes data collection (May-August 2026)
- Full evaluation sample (n\~3,080; \~22 girls/school): all girls in the Kilonga 2 sample across the 140 schools are eligible for the cognitive, self-reported psychosocial, and non-biospecimen health outcomes, collected at the social-science endline.
- Biomarker subsample (n\~1,360; \~17 girls/school): girls attending one of the 80 schools selected for the health biomarker subsample (logistically accessible for biospecimen collection and cold-chain maintenance) are additionally eligible for salivary cortisol and blood-based C-reactive protein outcomes.
- Informed consent obtained from parent/legal guardian, and assent obtained from the participant herself
You may not qualify if:
- Adolescents (or their parent/legal guardian) who refuse to participate or who withdraw consent/assent at any time
- Adolescents for whom sample collection is judged impossible or contraindicated at the time of collection (e.g., health status precluding collection)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California Santa Cruzlead
- Paris School of Economicscollaborator
- Laboratoire d'Analyses Médicales Malagasy (LA2M)collaborator
- Consultant Associatescollaborator
- Care Internationalcollaborator
Study Sites (1)
Laboratoire d'Analyses Médicales Malagasy
Antananarivo, Madagascar
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Audrie Lin, PhD, MPH
University of California Santa Cruz
- PRINCIPAL INVESTIGATOR
Karen Macours, PhD
Paris School of Economics
- PRINCIPAL INVESTIGATOR
Duncan Webb, PhD
Nova School of Business and Economics
- PRINCIPAL INVESTIGATOR
Mariachiara Iannuzzi, MS
Paris School of Economics
- PRINCIPAL INVESTIGATOR
Oscar M Díaz, MS
Paris School of Economics
- PRINCIPAL INVESTIGATOR
William Amedanou, MS
Paris School of Economics
- PRINCIPAL INVESTIGATOR
Juliet Ellenbach, BS
University of California Santa Cruz
- PRINCIPAL INVESTIGATOR
Eliane Z Ralison
Consultant Associates
- PRINCIPAL INVESTIGATOR
Andry M Andrianarivelo, MD
Laboratoire d'Analyses Médicales Malagasy
- PRINCIPAL INVESTIGATOR
Ianja I Razanadrakoto, MD
Laboratoire d'Analyses Médicales Malagasy
- PRINCIPAL INVESTIGATOR
Tantely J Ramontalambo, MD
Laboratoire d'Analyses Médicales Malagasy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The outcome assessment team is separate from the implementation team, however due to the nature of the interventions there may be intervention contents visible during the assessment. Data analysis will be masked to randomization status of clusters.
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2026
First Posted
July 14, 2026
Study Start
October 1, 2024
Primary Completion
August 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 14, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made publicly available. Per the approved protocol (UCSC IRB: HS-FY2025-210), all survey and biospecimen data are de-identified at the point of collection; identifiers are stored separately from research data and accessible only to authorized project personnel.